Top Buy
| Security | Buy | Sell | Buy (1M) | Sell (1M) ▼ | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| EssilorLuxottica SA | 3 | 0 | 1 | 0 | €207.50 | €224.50 | 8.193% |
| Novo Nordisk A/S | 5 | 0 | 1 | 0 | €185.00 | €195.00 | 5.405% |
| Fresenius Medical Care AG & Co KGaA ST | 2 | 0 | 1 | 0 | €37.62 | €50.00 | 32.908% |
| Trinity Biotech ADR | 25 | 0 | 2 | 0 | €0.41 | - | - |
| Verastem Inc. | 14 | 0 | 0 | 0 | €2.46 | €16.16 | 556.963% |
| Xeris Biopharma Holdings Inc. | 5 | 0 | 0 | 0 | €2.57 | €4.62 | 79.545% |
| Abbott Laboratories | 19 | 0 | 1 | 0 | €105.22 | €116.25 | 10.481% |
| UCB S.A. | 1 | 0 | 1 | 0 | €162.90 | €210.00 | 28.913% |
| Cigna Corp. | 27 | 0 | 5 | 0 | €328.50 | €360.76 | 9.820% |
| Vertex Pharmaceuticals Inc. | 58 | 2 | 1 | 0 | €441.65 | €459.80 | 4.110% |
| Perrigo Co. plc | 4 | 0 | 0 | 0 | €25.29 | €35.01 | 38.416% |
| Bausch Health Companies Inc. | 7 | 0 | 1 | 0 | €6.30 | €12.95 | 105.697% |
| Myriad Genetics | 4 | 3 | 0 | 0 | €24.80 | €22.15 | -10.696% |
| Novavax Inc. | 5 | 1 | 0 | 0 | €11.85 | €21.04 | 77.526% |
| Dynavax Technologies Corp | 4 | 0 | 0 | 0 | €10.09 | €26.95 | 167.093% |
| Edwards Lifesciences Corp. | 35 | 1 | 3 | 0 | €62.74 | €82.91 | 32.145% |
| Grifols S.A. | 1 | 0 | 0 | 0 | €10.28 | - | - |
| Cytokinetics Inc. | 35 | 1 | 5 | 0 | €50.50 | €83.13 | 64.616% |
| Halozyme Therapeutics Inc. | 24 | 0 | 3 | 0 | €56.80 | €58.12 | 2.325% |
| Ipsen S.A. | 1 | 0 | 0 | 0 | €109.90 | €109.00 | -0.819% |
| Clinuvel Pharmaceuticals | 1 | 0 | 0 | 0 | €9.19 | - | - |
| Insulet Corp. | 16 | 0 | 1 | 0 | €208.90 | €216.71 | 3.737% |
| Masimo Corp. | 7 | 0 | 0 | 0 | €101.80 | €151.02 | 48.354% |
| EyePoint Pharmaceuticals Inc. | 18 | 1 | 1 | 0 | €8.05 | €27.83 | 245.899% |
| Smith & Nephew plc ADR | 3 | 0 | 0 | 0 | €28.00 | - | - |